Medicared For All Logo

Bradley Ekstrand MD in San Francisco, California

Home California San Francisco

Bradley Ekstrand MD has Medical Oncology as his primary medical specialty. Their primary office is: 400 Parnassus Ave in San Francisco, California. There is an additional office location, for a total of two, for Bradley Ekstrand MD that can be viewed further down.

They're a part of the: Ucsf Medical Group Business Services medical group which has around 1,073 members. You can call their office at - to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Yale University School Of Medicine and graduated in 1997 (around 27 years of experience). They are listed as doing telehealth appointments.


Bradley C Ekstrand MD Office Phone and Directions

Bradley Ekstrand MD
Ucsf Medical Group Business Services
400 Parnassus Ave
San Francisco, California 94143
-


Patient Ratings
Please rate your experience with Bradley Ekstrand MD below to help others make a more informed decision. Thanks!
Current Rating: Loading...


Enter a starting address:


Healthcare Info for Bradley Ekstrand MD

Additional Medical Specialties Include:
HEMATOLOGY/ONCOLOGY

Medical School: Yale University School Of Medicine
Graduation Year: 1997
The Primary Medical Specialty for Bradley Ekstrand MD is listed as: Medical Oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 27
PAC (PECOS ID)#: 8729982855
NPI #: 1528125135
NPI Created On: 01/02/2007
NPI Last Updated Listed as: 05/25/2011
Primary Taxonomy Code: 207RH0003X
License Number:
A71243
Listed Gender: Male

Procedures, Services, Charges


Services and Procedures include:

  1. Insertion of needle into vein for collection of blood sample
  2. Collection of blood specimen from a completely implantable venous access device
  3. Complete blood cell count (red cells, white blood cell, platelets), automated test
  4. Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
  5. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
  6. Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
  7. Hormonal anti-neoplastic chemotherapy administration beneath the skin or into muscle
  8. Infusion of chemotherapy into a vein up to 1 hour
  9. Infusion of chemotherapy into a vein
  10. Infusion of different chemotherapy drug or substance into a vein up to 1 hour
  11. Irrigation of implanted venous access drug delivery device
  12. New patient office or other outpatient visit, typically 60 minutes
  13. Established patient office or other outpatient visit, typically 15 minutes
  14. Established patient office or other outpatient, visit typically 25 minutes
  15. Established patient office or other outpatient, visit typically 40 minutes
  16. Initial hospital inpatient care, typically 70 minutes per day
  17. Subsequent hospital inpatient care, typically 25 minutes per day
  18. Subsequent hospital inpatient care, typically 35 minutes per day
  19. Physician telephone patient service, 11-20 minutes of medical discussion
  20. Physician telephone patient service, 21-30 minutes of medical discussion

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788350173

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12


Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Context of payment:: ;G2780615;EPRINTS;10649246

Record ID:: 845872667

Being Disputed:: No

Product Related: Yes


Payments Total: $124

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832494091

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: INLYTA

Open Associated Drug #1: 0069-0145-01


Payments Total: $8

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832511159

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: INLYTA

Open Associated Drug #1: 0069-0145-01


Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832517693

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: INLYTA

Open Associated Drug #1: 0069-0145-01


Payments Total: $8

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832825665

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: INLYTA

Open Associated Drug #1: 0069-0145-01


Payments Total: $8

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832825671

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: INLYTA

Open Associated Drug #1: 0069-0145-01


Payments Total: $8

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832888947

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: INLYTA

Open Associated Drug #1: 0069-0145-01


Payments Total: $8

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 833071901

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: INLYTA

Open Associated Drug #1: 0069-0145-01


Payments Total: $26

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 833272473

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: INLYTA

Open Associated Drug #1: 0069-0145-01


Additional Office Locations

1. Ucsf Medical Group Business Services
3100 San Pablo Ave
Berkeley, CA 94702
Group Members: 1,073

Phone: -

Enter a starting address:


Medical Oncology Professionals in San Francisco

2200 Ofarrell St
San-francisco, CA
Permanente Medical Group Inc

2425 Geary Blvd
San-francisco, CA
Permanente Medical Group Inc

2238 Geary Blvd
San-francisco, CA
Permanente Medical Group Inc

400 Parnassus Ave
San-francisco, CA
University Of California San Francisco

2330 Post St
San-francisco, CA
University Of California San Francisco

2200 Ofarrell St
San-francisco, CA
Permanente Medical Group Inc

Providers in Ucsf Medical Group Business Services

1.Daniel

400 Parnassus Ave
San Francisco Ca 94143-2202
Ucsf Medical Group Business Services
Internal Medicine

2.Shoko Abe

400 Parnassus Ave
San Francisco Ca 94143-2202
Ucsf Medical Group Business Services
General Surgery

3.Theodore Abraham

400 Parnassus Ave
San Francisco Ca 94143-2202
Ucsf Medical Group Business Services
Cardiovascular Disease (cardiology)

4.Maria Abraham

400 Parnassus Ave
San Francisco Ca 94143-2202
Ucsf Medical Group Business Services
Cardiovascular Disease (cardiology)

5.Donald Abrams Md

400 Parnassus Ave
San Francisco Ca 94143-2202
Ucsf Medical Group Business Services
Medical Oncology

6.Deborah Adey

400 Parnassus Ave
San Francisco Ca 94143-2202
Ucsf Medical Group Business Services
Nephrology

View all 1,073 members of Ucsf Medical Group Business Services medical group